Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AGMB compared with IMRX: revenue, margins and what each company keeps, and the suppliers and customers both name
AGMB
Agomab Therapeutics NV
Change
Mkt cap
Revenue
Revenue
IMRX
Immuneering Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
AGMB
Agomab Therapeutics NV
vs
IMRX
Immuneering Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
AGMB: latest quarter not drawable. IMRX: latest quarter not drawable.
Method
›
AGMB
Agomab Therapeutics NV
Change
6.68
▼
−10.81%
· post 6.68
Mkt cap
$255.9M
IMRX
Immuneering Corp
Change
3.50
▼
−6.54%
· post 3.50
Closed
Nov 2 '26
Mkt cap
$225.8M
vs
Compare
Closed
Nov 2 '26
AGMB
Agomab Therapeutics NV
vs
IMRX
Immuneering Corp
6.68
▼
−10.81%
post 6.68
Price
3.50
▼
−6.54%
post 3.50
$255.9M
Mkt cap
$225.8M
Change
Change
AGMB
6.68
▼
−10.81%
vs
IMRX
3.50
▼
−6.54%
Closed
Nov 2 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AGMB, solid
IMRX, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AGMB
0
None
Shared
0
No disclosed counterparties: AGMB.
Only IMRX
4
LLY
Eli Lilly
supplier
REGN
Regeneron Pharmaceuticals
supplier
—
BioArkive
unlisted
supplier
—
Aventis
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR